1042768-00-2

Usage

Uses

Used in Pharmaceutical Industry:
3-CYCLOPROPYL-5-DIFLUOROMETHYL-1H-PYRAZOLE is used as a building block for the synthesis of various biologically active molecules. Its unique structure and reactivity make it a valuable component in the development of new pharmaceutical compounds with potential therapeutic applications.
Used in Agricultural Industry:
3-CYCLOPROPYL-5-DIFLUOROMETHYL-1H-PYRAZOLE is used as a potential pesticide, fungicide, and herbicide. Its structural features and functional groups contribute to its effectiveness in controlling pests, fungi, and weeds, making it a valuable tool in agricultural practices.
Used in Organic Electronics:
3-CYCLOPROPYL-5-DIFLUOROMETHYL-1H-PYRAZOLE is used in the development of new materials for organic electronics. Its unique properties and reactivity make it a promising candidate for applications in this field, contributing to the advancement of electronic devices and technologies.

Upstream product

• 765-43-5 Cyclopropyl methyl ketone 

Downstream Products

• 1288340-67-9 5-cyclopropyl-3-(difluoromethyl)-1-(2-fluoro-4-nitrophenyl)-1H-pyrazole 
• 1288340-66-8 3-cyclopropyl-5-(difluoromethyl)-1-(2-fluoro-4-nitrophenyl)-1H-pyrazole 
• 1288340-69-1 4-(5-cyclopropyl-3-(difluoromethyl)-1H-pyrazol-1-yl)-3-fluoroaniline 
• 1288340-68-0 4-(3-cyclopropyl-5-(difluoromethyl)-1H-pyrazol-1-yl)-3-fluoroaniline 
• 1002032-66-7 2-(5-cyclopropyl-3-(difluoromethyl)-1H-pyrazol-1-yl) acetic acid 

Relevant academic research and scientific papers

INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION

Compounds and pharmaceutically acceptable salts thereof, and compositions and methods for treating human immunodeficiency virus (HIV) infection are set forth.

INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION

Compounds of Formula (I), including pharmaceutically acceptable salts thereof, and compositions and methods for treating human immunodeficiency virus (HIV) infection are set forth:

INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION

Compounds of Formula (I), including pharmaceutically acceptable salts thereof, and compositions and methods for treating human immunodeficiency virus (HIV) infection are set forth.

QUINAZOLINYL-INDAZOLE DERIVATIVES AND THEIR USE AS INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION

Compounds of Formula I, including pharmaceutically acceptable salts thereof, and compositions and methods for treating human immunodeficiency virus (HIV) infection are set forth: Formula (I):

INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION

Compounds of Formula (I), including pharmaceutically acceptable salts thereof, and compositions and methods for treating human immunodeficiency virus (HIV) infection are set forth.

PYRAZOLE DERIVATIVES AS MODULATORS OF CALCIUM RELEASE -ACTIVATED CALCIUM CHANNEL

Disclosed are novel calcium release-activated calcium (CRAC) channel inhibitors, methods for preparing them, pharmaceutical compositions containing them, and methods of treatment using them. The present disclosure also relates to methods for treating non-small cell lung cancer (NSCLC) with CRAC inhibitors, and to methods for identifying therapeutics for treating and of diagnosing cancer.